US EditionPublished • loading... • Updated
New FDA-approved glasses can slow nearsightedness in kids
The FDA approved Essilor Stellest glasses to slow myopia progression in children ages 6–12, showing a 70% reduction in worsening nearsightedness after two years, company data shows.
- The U.S. Food and Drug Administration cleared EssilorLuxottica's Essilor Stellest spectacle lenses for children ages 6 to 12, now being rolled out in the United States.
- Researchers say increased indoor and screen time has driven demand for new treatments, and until now doctors had few options beyond MiSight contact lenses and off-label medicated eye drops.
- The FDA said the lenses' optical design uses 11 concentric rings, and company data showed a 70% reduction in myopia progression and a 50% reduction in eye lengthening.
- Major U.S. vision insurers are expected to cover lenses for children who meet prescribing criteria, and EssilorLuxottica lists a suggested retail price of US$450 while some parents and physicians prefer glasses over contacts.
- Independent researchers in the U.S. and other countries are conducting studies to confirm company results, while Dr. Michael Repka, Johns Hopkins School of Medicine, leads an NIH-supported U.S. study seeking domestic data.
Insights by Ground AI
27 Articles
27 Articles
Coverage Details
Total News Sources27
Leaning Left2Leaning Right0Center24Last UpdatedBias Distribution92% Center
Bias Distribution
- 92% of the sources are Center
92% Center
C 92%
Factuality
To view factuality data please Upgrade to Premium
